Evolent Health (EVH) Invested Capital (2013 - 2026)

Evolent Health has reported Invested Capital for 14 years, with the latest figure at $396.4 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital fell 64.2% year-over-year to $396.4 million; the trailing twelve-month figure through Mar 2026 stood at $396.4 million (down 64.2% YoY), and the FY2025 full-year result was $415.2 million, down 64.6% from the prior year.
• Invested Capital for Q1 2026 stood at $396.4 million, down from $415.2 million in the prior quarter.
• The five-year high for Invested Capital was $1.2 billion in Q4 2024, with the low at $396.4 million in Q1 2026.
• Average Invested Capital over 5 years is $909.8 million, with a median of $1.0 billion recorded in 2024.
• Year-over-year, Invested Capital soared 83.53% in 2023 and slumped 64.6% in 2025.
• Tracing EVH's Invested Capital over 5 years: stood at $859.4 million in 2022, then rose by 24.24% to $1.1 billion in 2023, then increased by 9.84% to $1.2 billion in 2024, then tumbled by 64.6% to $415.2 million in 2025, then declined by 4.53% to $396.4 million in 2026.
• The last three Invested Capital figures came in at $396.4 million (Q1 2026), $415.2 million (Q4 2025), and $847.4 million (Q3 2025), per Business Quant data.

Peer Comparison